Indicators such as stroke volume (SV), cardiac output (CO), end-diastolic volume, ejection fraction, stroke volume variation (SVV), pulse pressure variation (PPV), and systolic pressure variations (SPV), among others, are important not only for diagnosis of disease, but also for “real-time,” i.e., continual, monitoring of clinically significant changes in a subject. For example, health care providers are interested in changes in preload dependence, fluid responsiveness, or volume responsiveness as well as, for example, central-to-peripheral decoupling in both human and animal subjects. Few hospitals are therefore without some form of equipment to monitor one or more cardiac indicators in an effort to provide a warning that one or more of the indicated changes are occurring in a subject. Many techniques, including invasive techniques, non-invasive techniques, and combinations thereof, are in use and even more have been proposed in the literature.
Methods for monitoring central-to-peripheral arterial pressure decoupling in a subject are described. The methods involve the comparison of parameters such as vascular impedance, arterial compliance, and central aortic and peripheral arterial pressures that can be determined from flow and pressure measurements at central aortic and peripheral arterial locations. The relationship between these parameters provides an indication of central-to-peripheral arterial pressure decoupling.
The methods for monitoring central-to-peripheral arterial pressure decoupling in a subject using vascular impedance involve measuring central aortic pressure, central aortic flow, and peripheral arterial pressure in the subject. Then calculating a central systemic vascular impedance from the central aortic pressure and the central aortic flow, and a peripheral systemic vascular impedance from the peripheral arterial pressure and the central aortic flow. The central systemic vascular impendence is compared to the peripheral systemic vascular impedance, and central-to-peripheral arterial pressure decoupling is indicated if the subject's peripheral systemic vascular impedance is greater than the subject's central systemic vascular impedance.
The methods for monitoring central-to-peripheral arterial pressure decoupling in a subject using arterial compliance involve measuring central aortic pressure, central aortic flow, and peripheral arterial pressure in the subject. Then calculating a central systemic arterial compliance from the central aortic pressure and the central aortic flow, and a peripheral systemic arterial compliance from the peripheral arterial pressure and the central aortic flow. The central systemic arterial compliance is compared to the peripheral systemic arterial compliance, and central-to-peripheral arterial pressure decoupling is indicated if the subject's peripheral systemic arterial compliance is greater than the subject's central systemic arterial compliance.
The methods for monitoring central-to-peripheral arterial pressure decoupling in a subject using central aortic pressure and peripheral arterial pressure involve measuring the subject's central aortic pressure and the subject's peripheral arterial pressure. The subject's central aortic pressure is compared to the subject's peripheral arterial pressure, and central-to-peripheral arterial pressure decoupling is indicated if the subject's central aortic pressure is greater than the subject's peripheral arterial pressure.
Methods for monitoring central-to-peripheral arterial pressure decoupling, i.e., hyperdynamic hemodynamic conditions are described. These methods involve the comparison of parameters such as impedance, compliance, and pressure that can be determined from flow and pressure measurements at central aortic and peripheral arterial locations. The relationship between the parameters at the central aortic and peripheral arterial locations provides an indication of central-to-peripheral arterial pressure decoupling. Specifically, when peripheral impedance or pressure values fall to levels below the analogous central impedance or pressure parameter values (or vice versa for compliance), central-to-peripheral arterial pressure decoupling is indicated. These methods can alert a user that a subject is experiencing central-to-peripheral arterial pressure decoupling, which can enable a clinician to appropriately provide treatment to the subject.
As used herein, the phrases hyperdynamic and vasodilation mean a condition in which the arterial peripheral pressure and flow are decoupled from the central aortic pressure and flow, and the term peripheral arteries is intended to mean arteries located away from the heart, e.g., radial, femoral, or brachial arteries. Decoupled arterial pressure means that the normal relationship between the arterial peripheral pressure and the central aortic pressure is not valid and the arterial and peripheral arterial pressure can not be used to determine the central arterial pressure. This also includes conditions in which the peripheral arterial pressure is not proportional or is not a function of the central aortic pressure. Under normal hemodynamic conditions, blood pressure increases the further away from the heart the measurement is taken. Such a pressure increase is shown in
This normal hemodynamic relationship of pressures, i.e., an increase in pressure away from the heart, is often relied upon in medical diagnosis. However, under hyperdynamic/vasodilation conditions, this relationship can become inverted with the arterial pressure becoming lower than the central aortic pressure. This reversal has been attributed, for example, to arterial tone in the peripheral vessels, which is suggested to impact the wave reflections in the arterial system. Such a hyperdynamic condition is shown in
A first method for monitoring central-to-peripheral arterial pressure decoupling in a subject is shown as a flow chart in
Central systemic vascular impedance can be calculated by dividing the central aortic pressure by the central aortic flow as follows:
where Za is systemic vascular impedance (the subscript a indicates that the measurement is performed at the level of the aorta), Pa is the power spectrum of aortic pressure, Qa is the power spectrum of aortic flow, j is the imaginary unit, indicating a complex function, and the frequency, ω, is 2πf. As will be clear to those of skill in the art, all the mathematical operations described here are performed in the frequency domain. Any number of harmonics of the pressure signal or the flow signal can be used, e.g., the first 10, or the first 20 harmonics of the pressure and flow signals. The power spectrum of the pressure and flow signals could be calculated, e.g., with a Fast Fourier Transform (FFT). Other methods to calculate the power spectrum of a signal are known to those of skill in the art. Similarly, peripheral arterial impedance can be calculated by dividing the peripheral arterial pressure by the central aortic flow as follows:
where Zp is peripheral systemic vascular impedance (the subscript p indicating the measurement is performed in a peripheral vessel), Pp is the power spectrum of the peripheral arterial pressure, Qa is the power spectrum of the peripheral arterial flow, j is the imaginary unit, indicating a complex function, and the frequency, ω, is 2πf. Whether a subject's peripheral systemic vascular impedance is greater than the subject's central systemic vascular impedance (i.e., whether central-to-peripheral arterial pressure decoupling is indicated (PDT)) can be expressed mathematically as follows:
PDI=Za(jω)>Zp(jω)
The degree of central-to-peripheral arterial pressure decoupling in subjects in which central-to-peripheral arterial pressure decoupling is indicated can be expressed mathematically as follows:
In this relationship, the degree of the peripheral decoupling will be shown as 0 when the central systemic vascular impedance is lower than the peripheral systemic vascular impedance (i.e. no peripheral decoupling is indicated) and the degree of peripheral decoupling will be a equal to the difference between the central systemic vascular impedance and the peripheral systemic vascular impedance when the central systemic vascular impedance is greater than the peripheral systemic vascular impedance (i.e. peripheral decoupling is indicated).
Further, the difference between the central and peripheral systemic vascular impedances can be measured continuously, which will indicate the degree of the difference between the central systemic vascular impedance and the peripheral systemic vascular impedance.
PD=Za(jω)−Zp(jω)
When using this relationship, if PD is greater than zero, peripheral pressure decoupling is indicated, and the greater the value of PD, the greater the peripheral decoupling. When PD is less than zero, normal conditions are indicated. If PD is less than zero by more than 25%, peripheral vasoconstriction will be indicated.
The degree of peripheral decoupling could be given in % as follows:
Or continuously as follows:
As used with the methods described herein, a subject's central aortic pressure can be directly or indirectly monitored. A subject's central aortic pressure can be directly monitored, for example, with one or more pressure transducers introduced into different parts of the aorta (e.g., ascending aorta, aortic arch, thoracic aorta, abdominal aorta). For direct measurement, a pressure transducer can be, for example, positioned in the subject's aortic arch, ascending aorta thoracic aorta, or abdominal aorta. Other pressure meters and locations for their placement are known to those of skill in the art. A subject's central aortic pressure also can be determined from a signal proportional to, derived from, or a function of the subject's central aortic pressure. A signal proportional to, derived from, or a function of the subject's central aortic pressure can be measured, for example by one or more of central bioimpedence plethysmography, non-invasive tonometry, ultrasound, or pulse oximetry. Other signals proportional to or a function of a subject's central aortic pressure and methods for their measurement are known to those of skill in the art.
Also as used with the methods described herein, a subject's central aortic flow can be directly or indirectly monitored. A subject's central aortic flow can be directly monitored, for example, with one or more flow meters introduced into different parts of the aorta (e.g., ascending aorta, aortic arch, thoracic aorta, abdominal aorta). For direct measurement, a flow meter can be, for example, positioned in the subject's aortic arch, ascending aorta thoracic aorta, or abdominal aorta. Other flow meters and locations for their placement are known to those of skill in the art. The subject's central aortic flow also can be determined from a signal proportional to, derived from, or a function of the subject's central aortic flow. A signal proportional to, derived from, or a function of the subject's central aortic flow can be measured, for example by one or more of Doppler, ultrasound, bioimpedance, TEE, or Swan-Ganz Catheter. Other signals proportional to or a function of a subject's central aortic flow and methods for their measurement are known to those of skill in the art.
Further as used with the methods described herein, a subject's peripheral arterial pressure can be directly or indirectly monitored. A subject's peripheral arterial pressure can be directly monitored, for example, with one or more pressure transducers introduced into one or two radial, brachial, or femoral vessels. For direct measurement, a pressure transducer can be, for example, positioned in one or more of the subject's radial, brachial, or femoral vessels. Other pressure meters and locations for their placement are known to those of skill in the art. A subject's peripheral arterial pressure also can be determined from a signal proportional to, derived from, or a function of the subject's peripheral arterial pressure. A signal proportional to, derived from, or a function of the subject's peripheral arterial pressure can be measured, for example by one or more of central bioimpedence plethysmography, non-invasive tonometry, ultrasound, cuff blood pressure, or pulse oximetry. Other signals proportional to or a function of a subject's peripheral arterial pressure and methods for their measurement are known to those of skill in the art.
A further method for monitoring central-to-peripheral arterial pressure decoupling in a subject is shown as a flow chart in
Central systemic arterial compliance can be calculated by first measuring the peripheral resistance for f=0 of the spectrum as:
Where Rp is peripheral resistance, Za is systemic arterial vascular impedance, Pa is the power spectrum of the aortic pressure, and Qa is the power spectrum of the aortic flow. If we assume a two-element Compliance-Resistance model of the arterial system as shown in
where the frequency, ω, is 2πf. Then the central systemic arterial compliance for the first ten harmonics is:
(Those of skill in the art will understand that any number of harmonics can be used to measure the central systemic arterial compliance.) Similarly, the reactive component of the peripheral systemic vascular pressure impedance is:
And the peripheral systemic arterial compliance for the first ten harmonics is:
Whether a subject's peripheral systemic arterial compliance is greater than the subject's central systemic arterial compliance (i.e., whether central-to-peripheral arterial pressure decoupling is indicated) can be expressed mathematically as follows:
PDI=Cp>Ca
The degree of central-to-peripheral arterial pressure decoupling in subjects in which central-to-peripheral arterial pressure decoupling is indicated can be expressed mathematically as follows:
In this relationship the degree of the peripheral decoupling will be shown as 0 when the peripheral systemic arterial compliance is lower than the central systemic arterial compliance (i.e. no peripheral decoupling is indicated) and the degree of peripheral decoupling will be a equal to the difference between the peripheral systemic arterial compliance and the central systemic arterial compliance when the peripheral systemic arterial compliance is greater than the central systemic arterial compliance (i.e. peripheral decoupling is indicated).
Further, the difference between the peripheral systemic arterial compliance and the central systemic arterial compliance can be measured continuously, which will indicate the degree of the difference the difference between the peripheral systemic arterial compliance and the central systemic arterial compliance:
PD=Cp−Ca
When using this relationship, if PD is greater than zero, peripheral pressure decoupling is indicated, and the greater the value of PD, the greater the peripheral decoupling. When PD is less than zero, normal conditions are indicated. If PD is less than zero by more than 25%, peripheral vasoconstriction will be indicated.
The degree of peripheral decoupling could be given in % as follows:
Or continuously as follows:
An additional method for monitoring central-to-peripheral arterial pressure decoupling in a subject is shown as a flow chart in
Whether a subject's central aortic pressure is greater than the subject's peripheral arterial pressure (i.e., whether central-to-peripheral arterial pressure decoupling is indicated) can be expressed mathematically as follows:
PDI=Pa(t)>Pp(t)
The degree of central-to-peripheral arterial pressure decoupling in subjects in which central-to-peripheral arterial pressure decoupling is indicated can be expressed mathematically as follows:
As in the methods described above, the degree of peripheral decoupling could be measured continuously as the difference between the central aortic pressure and the peripheral arterial pressure:
PD=Pa(t)−Pp(t)
When using this relationship, if PD is greater than zero, peripheral pressure decoupling is indicated, and the greater the value of PD, the greater the peripheral decoupling. When PD is less than zero, normal conditions are indicated. If PD is less than zero by more than 25%, peripheral vasoconstriction will be indicated.
The degree of peripheral decoupling could be indicated in % as follows:
Or continuously:
The difference between a subject's peripheral arterial impedance, compliance, or pressure, and the subject's central aortic impedance, compliance, or pressure can be continually monitored. Additionally, the degree of central-to-peripheral arterial pressure decoupling can be monitored, once decoupling is indicated, by calculating the difference between the subject's peripheral arterial impedance, compliance, or pressure, and the subject's central aortic impedance, compliance, or pressure. This difference in peripheral arterial impedance, compliance, or pressure, and central aortic impedance, compliance, or pressure also can be monitored continuously. Further, the difference between a subject's peripheral arterial impedance, compliance, or pressure, and the subject's central aortic impedance, compliance, or pressure can be displayed on a graphical user interface. For example, the difference can be displayed as a bar graph or a trend graph. When central-to-peripheral arterial pressure decoupling is detected, a user can be alerted, for example, by publishing a notice on a graphical user interface or by emitting a sound.
Examples of monitoring peripheral and aortic impedance and compliance (as well as resistance for a comparison) are shown in
The values P(k) are passed to or accessed from memory by a software module 310 comprising computer-executable code for implementing one or more aspects of the methods as described herein. The design of such a software module 310 will be straight forward to one of skill in the art of computer programming. Additional comparisons and/or processing as used by a method can be performed in additional modules such as 320 and 330.
If used, signal-specific data such as a record of difference values or other calculations can be stored in a memory region 315, which may also store other data or parameters as needed. These values may be entered using any known input device 400 in the conventional manner.
As illustrated by
Exemplary embodiments of the present invention have been described above with reference to block diagrams and flowchart illustrations of methods, apparatuses, and computer program products. One of skill will understand that each block of the block diagrams and flowchart illustrations, and combinations of blocks in the block diagrams and flowchart illustrations, respectively, can be implemented by various means including computer program instructions. These computer program instructions may be loaded onto a general purpose computer, special purpose computer, or other programmable data processing apparatus to produce a machine, such that the instructions which execute on the computer or other programmable data processing apparatus create a means for implementing the functions specified in the flowchart block or blocks.
The methods described herein further relate to computer program instructions that may be stored in a computer-readable memory that can direct a computer or other programmable data processing apparatus, such as in a processor or processing system (shown as 300 in
Accordingly, blocks of the block diagrams and flowchart illustrations support combinations of means for performing the specified functions, combinations of steps for performing the specified functions, and program instruction means for performing the specified functions. One of skill will understand that each block of the block diagrams and flowchart illustrations, and combinations of blocks in the block diagrams and flowchart illustrations, can be implemented by special purpose hardware-based computer systems that perform the specified functions or steps, or combinations of special purpose hardware and computer instructions.
The present invention is not limited in scope by the embodiments disclosed herein which are intended as illustrations of a few aspects of the invention and any embodiments which are functionally equivalent are within the scope of this invention. Various modifications of the methods in addition to those shown and described herein will become apparent to those skilled in the art and are intended to fall within the scope of the appended claims. Further, while only certain representative combinations of the method steps disclosed herein are specifically discussed in the embodiments above, other combinations of the method steps will become apparent to those skilled in the art and also are intended to fall within the scope of the appended claims. Thus a combination of steps may be explicitly mentioned herein; however, other combinations of steps are included, even though not explicitly stated. The term “comprising” and variations thereof as used herein is used synonymously with the term “including” and variations thereof and are open, non-limiting terms.
The application claims the benefit of U.S. Provisional Application No. 61/161,120 filed Mar. 18, 2009, entitled “Direct Measurements of Arterial Pressure Decoupling” and assigned to the assignee hereof and hereby incorporated by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
61161120 | Mar 2009 | US |